Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.02% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 2.17% |
| 4 | Financials | 2.1% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10301
CALL
Galectin Therapeutics
GALT
$347M
| $172K | ﹤0.01% |
62,500
+48,900
| +360% | +$120K |
|
10302
Energy Services of America
ESOA
$239M
| $172K | ﹤0.01% |
18,085
+7,468
| +70% | +$63.9K |
|
10303
PUT
Clean Energy Fuels
CLNE
$403M
| $172K | ﹤0.01% |
55,200
-30,600
| -36% | -$86.7K |
|
10304
CALL
VOC Energy
VOC
$53.9M
| $172K | ﹤0.01% |
34,800
-10,200
| -23% | -$50.7K |
|
10305
Digi International
DGII
$3.23B
| $171K | ﹤0.01% |
6,229
-11,906
| -66% | -$314K |
|
|
HUYA
10306
CALL
Huya Inc
HUYA
$529M
| $171K | ﹤0.01% |
33,600
-3,900
| -10% | -$16.8K |
|
10307
Relmada Therapeutics
RLMD
$512M
| $171K | ﹤0.01% |
52,846
-31,467
| -37% | -$102K |
|
10308
Emergent Biosolutions
EBS
$235M
| $171K | ﹤0.01% |
20,488
-325,866
| -94% | -$2.96M |
|
10309
PUT
Merchants Bancorp
MBIN
$2.52B
| $171K | ﹤0.01% |
3,800
+2,000
| +111% | +$88.7K |
|
10310
PUT
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.88B
| $171K | ﹤0.01% |
3,800
+3,600
| +1,800% | +$159K |
|
10311
CALL
Freedom Holding
FRHC
$9.34B
| $171K | ﹤0.01% |
1,800
-1,000
| -36% | -$86.9K |
|
10312
GrowGeneration
GRWG
$104M
| $171K | ﹤0.01% |
+80,078
| New | +$172K |
|
10313
CALL
Kornit Digital
KRNT
$775M
| $171K | ﹤0.01% |
6,600
-18,100
| -73% | -$333K |
|
10314
PUT
Sabesp
SBS
$16.2B
| $170K | ﹤0.01% |
53,112
+46,409
| +692% | +$148K |
|
10315
PUT
Amphastar Pharmaceuticals
AMPH
$889M
| $170K | ﹤0.01% |
3,500
-900
| -20% | -$39.5K |
|
10316
CALL
Crexendo
CXDO
$221M
| $170K | ﹤0.01% |
36,600
+500
| +1% | +$2.17K |
|
10317
PUT
Steris
STE
$22.7B
| $170K | ﹤0.01% |
700
-4,300
| -86% | -$1.01M |
|
10318
Nature's Sunshine
NATR
$266M
| $170K | ﹤0.01% |
12,451
-4,586
| -27% | -$65.8K |
|
|
OBE
10319
PUT
Obsidian Energy
OBE
$712M
| $170K | ﹤0.01% |
30,600
-8,200
| -21% | -$55K |
|
10320
PUT
inTEST
INTT
$179M
| $169K | ﹤0.01% |
23,200
+8,100
| +54% | +$67.2K |
|
10321
Nuveen Municipal Credit Opportunities Fund
NMCO
$588M
| $169K | ﹤0.01% |
14,495
-6,777
| -32% | -$77.1K |
|
10322
NewtekOne
NEWT
$376M
| $169K | ﹤0.01% |
13,569
-153,543
| -92% | -$1.95M |
|
10323
Ascent Industries
ACNT
$136M
| $169K | ﹤0.01% |
+17,418
| New | +$171K |
|
10324
CuriosityStream
CURI
$211M
| $169K | ﹤0.01% |
+88,396
| New | +$121K |
|
10325
PUT
TechTarget
TTGT
$278M
| $169K | ﹤0.01% |
6,900
-100
| -1% | -$2.81K |
|
Similar funds
Ken Griffin's Q3 2024 Portfolio in Review
As of Q3 2024, Ken Griffin held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Griffin's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Ken Griffin added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Ken Griffin's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Ken Griffin fully exited Domino's in Q3 2024, selling an estimated $186M.
- Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Ken Griffin opened 1,614 new positions and closed 1,610 in Q3 2024.
- Ken Griffin's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.